GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » 3-Year Dividend Growth Rate

Caplin Point Laboratories (BOM:524742) 3-Year Dividend Growth Rate : 124.10% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories 3-Year Dividend Growth Rate?

Caplin Point Laboratories's Dividends per Share for the three months ended in Mar. 2024 was ₹0.00.

The historical rank and industry rank for Caplin Point Laboratories's 3-Year Dividend Growth Rate or its related term are showing as below:

BOM:524742' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -35.6   Med: 23.3   Max: 124.1
Current: 124.1

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Caplin Point Laboratories was 124.10% per year. The lowest was -35.60% per year. And the median was 23.30% per year.

BOM:524742's 3-Year Dividend Growth Rate is ranked better than
99.05% of 317 companies
in the Drug Manufacturers industry
Industry Median: 10.2 vs BOM:524742: 124.10

During the past 12 months, Caplin Point Laboratories's average Dividends Per Share Growth Rate was 12.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 124.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Caplin Point Laboratories's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Caplin Point Laboratories's Dividend Yield % is 0.35%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Caplin Point Laboratories's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's 3-Year Dividend Growth Rate falls into.



Caplin Point Laboratories 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Caplin Point Laboratories  (BOM:524742) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Caplin Point Laboratories's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 16.01
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Caplin Point Laboratories was 0.16. The lowest was 0.01. And the median was 0.08.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Caplin Point Laboratories Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
INR 2.5000002023-09-142023-09-152023-10-06Cash Dividendsemi-annuallyINR:INR 1.000000
INR 2.0000002023-06-092023-06-092023-06-19Cash Dividendsemi-annuallyINR:INR 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Caplin Point Laboratories's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=4.5/1302.35
=0.35 %

Current Share Price is ₹1302.35.
Caplin Point Laboratories's Dividends per Share for the trailing twelve months (TTM) ended in Today is ₹4.5.

During the past 13 years, the highest Dividend Yield of Caplin Point Laboratories was 4.26%. The lowest was 0.06%. And the median was 0.49%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories 3-Year Dividend Growth Rate Related Terms>


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines